Staff View
Targets of transcription inhibition by the antibiotics lipiarmycin, GE23077, and salinamide

Descriptive

TitleInfo
Title
Targets of transcription inhibition by the antibiotics lipiarmycin, GE23077, and salinamide
Name (type = personal)
NamePart (type = family)
Degen
NamePart (type = given)
David D.
NamePart (type = date)
1981-
DisplayForm
David Degen
Role
RoleTerm (authority = RULIB)
author
Name (type = personal)
NamePart (type = family)
Ebright
NamePart (type = given)
Richard H.
DisplayForm
Richard H. Ebright
Affiliation
Advisory Committee
Role
RoleTerm (authority = RULIB)
chair
Name (type = personal)
NamePart (type = family)
Cai
NamePart (type = given)
Li
DisplayForm
Li Cai
Affiliation
Advisory Committee
Role
RoleTerm (authority = RULIB)
internal member
Name (type = personal)
NamePart (type = family)
Sinko
NamePart (type = given)
Patrick
DisplayForm
Patrick Sinko
Affiliation
Advisory Committee
Role
RoleTerm (authority = RULIB)
internal member
Name (type = personal)
NamePart (type = family)
Nickels
NamePart (type = given)
Bryce
DisplayForm
Bryce Nickels
Affiliation
Advisory Committee
Role
RoleTerm (authority = RULIB)
outside member
Name (type = corporate)
NamePart
Rutgers University
Role
RoleTerm (authority = RULIB)
degree grantor
Name (type = corporate)
NamePart
Graduate School - New Brunswick
Role
RoleTerm (authority = RULIB)
school
TypeOfResource
Text
Genre (authority = marcgt)
theses
OriginInfo
DateCreated (qualifier = exact)
2014
DateOther (qualifier = exact); (type = degree)
2014-01
Place
PlaceTerm (type = code)
xx
Language
LanguageTerm (authority = ISO639-2b); (type = code)
eng
Abstract (type = abstract)
The antibiotics lipiarmycin (Lpm), GE23077 (GE), and salinamide (Sal) function by inhibiting bacterial RNA polymerase (RNAP). In this work, the targets (and mechanisms) of transcription inhibition by Lpm, GE, and Sal are identified and characterized through a combination of genetic, biochemical, and structural approaches. Each of these compounds functions through a different target on the enzyme that does not significantly overlap the targets of other bacterial RNAP inhibitors. Elucidation of these targets may prove useful for antibacterial drug discovery and design. To define the functional target of Lpm, we isolated and sequenced 160 Lpm-resistant mutants. In the structure of RNAP, sites of substitutions conferring Lpm-resistance cluster to define the “Lpm target,” which includes residues in the RNAP switch-region, as well as one wall of the RNA exit channel. Biochemical experiments show that Lpm inhibits the RNAP-DNA interaction, and appears to function by trapping the RNAP clamp in a fully-to-partially closed state. To define the functional target of GE, we isolated and sequenced 35 GE-resistant mutants. In the structure of RNAP, sites of substitutions conferring GE-resistance cluster to define the “GE target,” which includes residues in the RNAP active-center subregions, the “β D2-loop” and the “link region.” Biochemical experiments reveal that GE inhibits nucleotide addition during transcription initiation, after open complex formation, but prior to phosphodiester bond formation. The crystal structure of RNAP in complex with GE confirms that GE binds to the GE target, and indicates that GE functions by precluding the binding of NTP substrates to the RNAP active-center "i site" and "i+1 site.” To define the functional target of Sal, we isolated and sequenced 47 Sal-resistant mutants. In the structure of RNAP, sites of substitutions conferring Sal-resistance cluster to define the “Sal target,” which includes residues in the RNAP active-center subregions: the “bridge-helix N-terminal hinge” (BH-HN), the “F-loop,” and the “link region.” Biochemical experiments reveal that Sal inhibits nucleotide addition during both transcription initiation and elongation. The crystal structure of RNAP in complex with Sal confirms that Sal binds to the Sal target, and suggests that Sal functions by trapping the BH-HN in a straight (unbent) conformation.
Subject (authority = RUETD)
Topic
Biomedical Engineering
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
Identifier (type = RULIB)
ETD
Identifier
ETD_5285
PhysicalDescription
Form (authority = gmd)
electronic resource
InternetMediaType
application/pdf
InternetMediaType
text/xml
Extent
xv, 173 p. : ill.
Note (type = degree)
Ph.D.
Note (type = bibliography)
Includes bibliographical references
Note (type = statement of responsibility)
by David D. Degen
Subject (authority = ETD-LCSH)
Topic
RNA polymerases
Subject (authority = ETD-LCSH)
Topic
Bacterial growth
RelatedItem (type = host)
TitleInfo
Title
Graduate School - New Brunswick Electronic Theses and Dissertations
Identifier (type = local)
rucore19991600001
Location
PhysicalLocation (authority = marcorg); (displayLabel = Rutgers, The State University of New Jersey)
NjNbRU
Identifier (type = doi)
doi:10.7282/T3125QRJ
Genre (authority = ExL-Esploro)
ETD doctoral
Back to the top

Rights

RightsDeclaration (ID = rulibRdec0006)
The author owns the copyright to this work.
RightsHolder (type = personal)
Name
FamilyName
Degen
GivenName
David
Role
Copyright Holder
RightsEvent
Type
Permission or license
DateTime (encoding = w3cdtf); (qualifier = exact); (point = start)
2014-01-04 19:22:15
AssociatedEntity
Name
David Degen
Role
Copyright holder
Affiliation
Rutgers University. Graduate School - New Brunswick
AssociatedObject
Type
License
Name
Author Agreement License
Detail
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.
RightsEvent
DateTime (encoding = w3cdtf); (qualifier = exact); (point = start)
2014-01-31
DateTime (encoding = w3cdtf); (qualifier = exact); (point = end)
2016-01-31
Type
Embargo
Detail
Access to this PDF has been restricted at the author's request. It will be publicly available after January 31st, 2016.
Copyright
Status
Copyright protected
Availability
Status
Open
Reason
Permission or license
Back to the top

Technical

RULTechMD (ID = TECHNICAL1)
ContentModel
ETD
OperatingSystem (VERSION = 5.1)
windows xp
Back to the top
Version 8.5.5
Rutgers University Libraries - Copyright ©2024